.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Multidisciplinary Management of Locoregional Non–Small Cell Lung Cancer

EP. 1: Mediastinal Staging in Non–Small Cell Lung Cancer

July 13th 2020

EP. 2: PACIFIC Trial: Durvalumab Following Chemotherapy for Stage III NSCLC

July 13th 2020

EP. 3: Durvalumab in Stage III NSCLC Based on Performance Status

July 13th 2020

EP. 4: Treating for Stage III NSCLC After Progression on Durvalumab

July 13th 2020

EP. 5: Varied Timing of IO Therapy in Patients With Stage III NSCLC

July 13th 2020

EP. 6: ADAURA: Osimertinib as Adjuvant Therapy in Stage III EGFR+ NSCLC

July 13th 2020

EP. 7: Molecular testing in Patients With Metastatic NSCLC

July 13th 2020

EP. 8: Integrating Perioperative Immunotherapy Strategies in NSCLC

July 13th 2020

EP. 9: Multidisciplinary Management of Patients With Stage III NSCLC

July 13th 2020